SINCE ITS FIRST reported use in the treatment of migraine by Maier 1 in 1926, ergotamine tartrate has become widely used in the treatment of this condition, and approximately 80% 2 of patients can be expected to respond to the drug.Serious side effects including circulatory disorders are uncommon when ergotamine tartrate is used in the treatment of migraine, 3,4,5,6,7 but well documented. 8,9,10,11,12 However Peters and Horton, 13 Silverskiold,14 Friedman, Brazil and von Storch, 15 and more recently Lucas and Falkowski 16 have reported the occurrence of tolerance and increased frequency of headaches in some patients taking frequent doses of ergotamine tartrate. These same authors 13,14,15,16 have also reported that such patients can experience withdrawal headaches on discontinuance of the drug.A marked increase in the frequency of the headaches was noted by the 24 patients included in this study whilst taking regular doses of ergotamine tartrate.